Zobrazeno 1 - 10
of 23
pro vyhledávání: '"MESH: Receptors, Somatostatin"'
Autor:
Leo J. Hofland, Meg Keil, Constantine A. Stratakis, M Nesterova, Paraskevi Xekouki, Dimitrios Avgeropoulos, Hervé Lefebvre, Rabia Cherqaoui, Ninet Sinaii, Zakariae Bram, Estelle Louiset, Christoforos Giatzakis
Publikováno v:
Journal of Clinical Endocrinology and Metabolism
Journal of Clinical Endocrinology and Metabolism, Endocrine Society, 2014, 99 (5), pp.E891-E901. ⟨10.1210/jc.2013-2657⟩
Journal of Clinical Endocrinology and Metabolism, 99(5), E891-E901. Endocrine Society
Journal of Clinical Endocrinology and Metabolism, Endocrine Society, 2014, 99 (5), pp.E891-E901. ⟨10.1210/jc.2013-2657⟩
Journal of Clinical Endocrinology and Metabolism, 99(5), E891-E901. Endocrine Society
Context: Somatostatin (SST) receptors (SSTRs) are expressed in a number of tissues, including the adrenal cortex, but their role in cortisol secretion has not been well characterized. Objectives: The objective of the study was to investigate the expr
Autor:
Nadia Henkous, Jean-Louis Guillou, Francois Gastambide, Thomas D. Prevot, Guillaume Martel, Jacques Epelbaum, Cécile Viollet, Daniel Béracochéa
Publikováno v:
Neuropsychopharmacology
Neuropsychopharmacology, Nature Publishing Group, 2017, 42 (8), pp.1647-1656. ⟨10.1038/npp.2016.281⟩
Neuropsychopharmacology, Nature Publishing Group, 2017, 42 (8), pp.1647-1656. ⟨10.1038/npp.2016.281⟩
International audience; Altered brain somatostatin functions recently appeared as key elements for the pathogenesis of stress-related neuropsychiatric disorders. The hippocampus exerts an inhibitory feedback on stress but the mechanisms involved rema
Autor:
Jean-José Maoret, Naïma Hanoun, Anny Souque, Pierre Cordelier, Frédéric Lopez, Jérôme Torrisani, Louis Buscail, Christiane Susini, Henrik Laurell
Publikováno v:
Endocrinology
Endocrinology, 2008, 149 (6), pp.3137-47. ⟨10.1210/en.2007-1525⟩
Endocrinology, 2008, 149 (6), pp.3137-47. ⟨10.1210/en.2007-1525⟩
International audience; Somatostatin is a neuropeptide that inhibits exocrine and endocrine secretions of several hormones and negatively regulates cell proliferation. These events are mediated through somatostatin engagement on one of five G protein
Autor:
Jesse Z. Dong, Michael D. Culler, Federica Barbieri, John E. Taylor, Leo J. Hofland, Marily Theodoropoulou, Henry Dufour, Philippe Jaquet, Tullio Florio, Alexandru Saveanu, Jacques-Pierre Moreau, Peter M. van Koetsveld, Renato Spaziante, Richard A Feelders, Günter K. Stalla, Ginette Gunz, Gianluigi Zona
Publikováno v:
Endocrine-Related Cancer
Endocrine-Related Cancer, BioScientifica, 2008, 15 (2), pp.583-96. ⟨10.1677/ERC-07-0271⟩
Endocrine-Related Cancer, 15(2), 583-596. Bioscientifica Ltd
Endocrine-Related Cancer, 2008, 15 (2), pp.583-96. ⟨10.1677/ERC-07-0271⟩
Endocrine-Related Cancer, BioScientifica, 2008, 15 (2), pp.583-96. ⟨10.1677/ERC-07-0271⟩
Endocrine-Related Cancer, 15(2), 583-596. Bioscientifica Ltd
Endocrine-Related Cancer, 2008, 15 (2), pp.583-96. ⟨10.1677/ERC-07-0271⟩
International audience; Dopamine D2 and somatostatin receptors (sstrs) were reported to affect non-functioning pituitary adenoma (NFPA) proliferation in vitro. However, the reported results differ according to the experimental conditions used. We est
Autor:
Mohamed, Amira, Blanchard, Marie-Pierre, Albertelli, Manuela, Barbieri, Federica, Brue, Thierry, Niccoli, Patricia, Delpero, Jean-Robert, Monges, Genevieve, Garcia, Stephane, Ferone, Diego, Florio, Tullio, Enjalbert, Alain, Moutardier, Vincent, Schonbrunn, Agnes, Gerard, Corinne, Barlier, Anne, Saveanu, Alexandru
Publikováno v:
Endocrine-Related Cancer
Endocrine-Related Cancer, BioScientifica, 2014, 21 (5), pp.691-704. ⟨10.1530/ERC-14-0086⟩
Endocrine-Related Cancer, 2014, 21 (5), pp.691-704. ⟨10.1530/ERC-14-0086⟩
Endocrine-Related Cancer, BioScientifica, 2014, 21 (5), pp.691-704. ⟨10.1530/ERC-14-0086⟩
Endocrine-Related Cancer, 2014, 21 (5), pp.691-704. ⟨10.1530/ERC-14-0086⟩
International audience; Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) raise difficult therapeutic problems despite the emergence of targeted therapies. Somatostatin analogs (SSA) remain pivotal therapeutic drugs. However, the tachyphylaxis
Autor:
More, Julie, Young, Jacques, Reznik, Yves, Raverot, Gérald, Borson-Chazot, Françoise, Rohmer, Vincent, Baudin, Eric, Coutant, Régis, Tabarin, Antoine, Renseigné, Non
Publikováno v:
Journal of Clinical Endocrinology and Metabolism
Journal of Clinical Endocrinology and Metabolism, Endocrine Society, 2011, 96 (5), pp.1213-22. ⟨10.1210/jc.2010-2276⟩
Journal of Clinical Endocrinology and Metabolism, Endocrine Society, 2011, 96 (5), pp.1213-22. ⟨10.1210/jc.2010-2276⟩
International audience; CONTEXT: Ectopic ACTH syndrome (EAS) in youngsters has seldom been reported and is poorly known. SETTING: We conducted a multicenter retrospective study involving 18 French tertiary hospitals. Cases of EAS presenting Cushing's
Autor:
Laurent Dumartin, Martin Hagedorn, Marie Bernadette Delisle, Sophie Le Guellec, Andreas Bikfalvi, Corinne Bousquet, Séverine Laval, Philippe Rochaix, Andrew V. Schally, Christiane Susini, Stéphane Pyronnet, Hanane Laklai
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America
Proceedings of the National Academy of Sciences of the United States of America, National Academy of Sciences, 2009, 106 (42), pp.17769-74. ⟨10.1073/pnas.0908674106⟩
Proceedings of the National Academy of Sciences of the United States of America, 2009, 106 (42), pp.17769-74. ⟨10.1073/pnas.0908674106⟩
Proceedings of the National Academy of Sciences of the United States of America, National Academy of Sciences, 2009, 106 (42), pp.17769-74. ⟨10.1073/pnas.0908674106⟩
Proceedings of the National Academy of Sciences of the United States of America, 2009, 106 (42), pp.17769-74. ⟨10.1073/pnas.0908674106⟩
International audience; The somatostatin receptor subtype 2 (sst2) behaves as a tumor suppressor when expressed and stimulated by its ligand somatostatin in pancreatic cancer. We reveal a mechanism underlying oncosuppressive action of sst2, whereby t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f8ad9fac560f3de0c2c0ab1a9946753
https://europepmc.org/articles/PMC2764925/
https://europepmc.org/articles/PMC2764925/
Publikováno v:
Journal of Neuroendocrinology
Journal of Neuroendocrinology, 2008, 20 (11), pp.1278-87. ⟨10.1111/j.1365-2826.2008.01780.x⟩
Journal of Neuroendocrinology, Wiley, 2008, 20 (11), pp.1278-87. 〈10.1111/j.1365-2826.2008.01780.x〉
Journal of Neuroendocrinology, 2008, 20 (11), pp.1278-87. ⟨10.1111/j.1365-2826.2008.01780.x⟩
Journal of Neuroendocrinology, Wiley, 2008, 20 (11), pp.1278-87. 〈10.1111/j.1365-2826.2008.01780.x〉
International audience; The ultradian pulsatile pattern of growth hormone (GH) secretion is markedly sexually dimorphic in rodents as in primates, but the neuroanatomical mechanisms of this phenomenon are not clear. In the arcuate nucleus of the hypo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::5d5002f898b6abef61300ea986980851
https://www.hal.inserm.fr/inserm-00313755/file/Table_1_-_copie.pdf
https://www.hal.inserm.fr/inserm-00313755/file/Table_1_-_copie.pdf
Autor:
P, Faissolle, K, Wagner-Mahler, J-C, Mas, M, Moreigne, A, Khalfi, V, Léonetti, M, Silvy, A, Barlier, H, Giudicelli
Publikováno v:
Archives de Pédiatrie
Archives de Pédiatrie, 2008, 15 (9), pp.1433-6. ⟨10.1016/j.arcped.2008.06.016⟩
Archives de Pédiatrie, Elsevier, 2008, 15 (9), pp.1433-6. ⟨10.1016/j.arcped.2008.06.016⟩
Archives de Pédiatrie, 2008, 15 (9), pp.1433-6. ⟨10.1016/j.arcped.2008.06.016⟩
Archives de Pédiatrie, Elsevier, 2008, 15 (9), pp.1433-6. ⟨10.1016/j.arcped.2008.06.016⟩
International audience; In children, pseudohypoparathyroidism (PHP) is a rare but classical cause of basal ganglia calcifications. It is caused by resistance to parathormone (PTH). Hypocalcemia, which may be symptomatic, is its main feature. We repor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::0cb40b1f5cf461fba4171842b06c2270
https://hal.science/hal-00398609
https://hal.science/hal-00398609
Autor:
Stéphane Pyronnet, Christiane Susini, Souad Najib, Hanane Laklai, Rania Azar, Corinne Bousquet
Publikováno v:
Molecular and Cellular Endocrinology
Molecular and Cellular Endocrinology, Elsevier, 2008, 286 (1-2), pp.230-7. ⟨10.1016/j.mce.2008.02.002⟩
Molecular and Cellular Endocrinology, Elsevier, 2008, 286 (1-2), pp.230. ⟨10.1016/j.mce.2008.02.002⟩
Molecular and Cellular Endocrinology, 2008, 286 (1-2), pp.230-7. ⟨10.1016/j.mce.2008.02.002⟩
Molecular and Cellular Endocrinology, Elsevier, 2008, 286 (1-2), pp.230-7. ⟨10.1016/j.mce.2008.02.002⟩
Molecular and Cellular Endocrinology, Elsevier, 2008, 286 (1-2), pp.230. ⟨10.1016/j.mce.2008.02.002⟩
Molecular and Cellular Endocrinology, 2008, 286 (1-2), pp.230-7. ⟨10.1016/j.mce.2008.02.002⟩
International audience; Since its discovery three decades ago as an inhibitor of GH release from the pituitary gland, somatostatin has attracted much attention because of its functional role in the regulation of a wide variety of physiological functi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::556db649b6a58763e20c9dd5ae7286f7
https://www.hal.inserm.fr/inserm-00409372
https://www.hal.inserm.fr/inserm-00409372